Individualized Wharton's jelly MSC & exosome protocols for cognitive & neural support
Stem cell therapy for Alzheimer's disease in Istanbul, Turkey
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat evaluates your neurological profile to design a tailored multi-route regenerative program.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Understanding the condition
Understanding the condition and our regenerative approach
Alzheimer's disease progressively disrupts the intricate synaptic networks of the hippocampus and cerebral cortex that allow us to encode new memories, recognize familiar surroundings, communicate fluently, and navigate daily life independently. Beneath the surface of amyloid and tau accumulation lies an active biological storm: overactivated microglia release chronic inflammatory cytokines, cerebral capillaries lose microvascular efficiency, and surviving neurons are deprived of the neurotrophic growth factors needed to maintain synaptic connections.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are investigated in Alzheimer's disease to calm this neuro-inflammatory cascade and nourish vulnerable neural circuits. Through potent immunomodulation and paracrine signaling, WJ-MSCs and their nanoscale exosomes work to downregulate pro-inflammatory mediators (such as TNF-α, IL-1β, and IL-6) and guide reactive M1 microglia toward a homeostatic, debris-clearing M2 phenotype. At the same time, they deliver brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and regenerative microRNAs that help protect existing synapses, support neurogenesis in the hippocampal dentate gyrus, improve cerebral microcirculation, and shield neuronal mitochondria from oxidative stress.
At our Istanbul clinic led by Uzm. Dr. Cihan Bolat, we review your neurological diagnosis, brain MRI, cognitive history, and current medications before designing a personalized multi-route protocol combining intrathecal, intravenous, and intranasal administration. Coordinated alongside your ongoing memory medications and family routines, our program aims to support cognitive clarity, daily orientation, mood and sleep stability, and meaningful engagement with loved ones.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
Key biological processes and therapeutic targets
Beyond protein aggregation, Alzheimer's disease is driven by chronic microglial neuroinflammation, synaptic pruning, blood-brain barrier breakdown, and declining neurotrophic support—core biological processes that WJ-MSCs and exosomes are designed to modulate and repair.
What our protocol aims to support
- Regulating central & systemic neuroinflammation: Our WJ-MSC and exosome protocols aim to shift inflammatory glial signaling toward a calmer, more neuroprotective tissue environment across memory networks.
- Supporting synaptic resilience & trophic pathways: Paracrine growth factors (BDNF, NGF, VEGF) and exosomal cargo aim to nourish surviving neural networks and support intercellular synaptic communication.
- Promoting cerebrovascular & metabolic balance: Systemic and targeted biologics aim to support endothelial health, blood-brain barrier integrity, and microvascular circulation supporting brain function.
- Seamless coordination with ongoing memory medications: Treatment in Istanbul is planned alongside your neurologist's prescribed cognitive therapies, sleep support, and daily family routines.
- 01
Chronic microglial & neuro-immune activation
Surrounding amyloid plaques and stressed axons, brain microglia become locked in a pro-inflammatory M1 state, releasing TNF-α and IL-1β that damage nearby healthy synapses and accelerate cognitive fatigue. Wharton's jelly MSCs and exosomes release immunomodulatory signals—including IL-10, TGF-β, and prostaglandin E2—that encourage microglia to return to a protective, reparative M2 phenotype. In this calmer state, glial cells are better able to clear cellular metabolic debris without harming adjacent neurons. Quieting chronic neuroinflammation helps protect the functional integrity of memory circuits.
- 02
Synaptic signaling & neurotrophic decline
Memory formation and recall depend on constant synaptic remodeling in the hippocampus and association cortex, a process fueled by brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). In Alzheimer's disease, declining trophic levels leave dendritic spines fragile and impair neurotransmitter communication. WJ-MSCs and WJ-MSC exosomes deliver exogenous neurotrophic factors and regulatory microRNAs that activate intracellular survival and plasticity pathways in surviving neurons. Supporting synaptic density and axonal signaling helps sustain attention, language, and daily cognitive engagement.
- 03
Cerebrovascular & blood-brain barrier stress
Microvascular narrowing, endothelial inflammation, and impaired glymphatic clearance reduce oxygen and glucose delivery to metabolically active cortical regions while allowing peripheral inflammatory signals to leak across the blood-brain barrier. Intravenous and central WJ-MSCs secrete VEGF and endothelial-protective factors that support capillary repair, microcirculation, and tight-junction stability. Better microvascular perfusion nourishes metabolically demanding hippocampal neurons and supports healthier metabolic waste clearance. Restoring neurovascular balance reinforces the foundation for cognitive stamina.
- 04
Oxidative & mitochondrial vulnerability
Neurons in memory networks consume vast amounts of cellular energy, making them highly vulnerable to mitochondrial dysfunction, calcium imbalance, and lipid peroxidation. Exosomes derived from Wharton's jelly MSCs transfer antioxidant enzymes, protective proteins, and mitochondrial-supportive RNAs directly to stressed neural cells. This intracellular support helps restore ATP synthesis and reduces free-radical damage to neuronal membranes. Protecting cellular bioenergetics helps surviving brain networks function more reliably throughout the day.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Addressing the Neuro-Inflammatory Driver of Synaptic Loss
In Alzheimer's disease, chronically activated microglia and astrocytes transition from protective caretakers into persistent sources of neurotoxic inflammation that strip away delicate synapses. Regenerative medicine targets this glial dysregulation directly rather than focusing on a single downstream protein alone. By calming inflammatory cytokines and restoring healthier microglial phagocytosis, biological therapy aims to protect the surviving neural architecture of the hippocampus and cortex. Preserving these synaptic bridges is essential for maintaining memory processing and daily orientation.
How WJ-MSCs & Exosomes Nourish Cognitive Networks
Wharton's jelly MSCs secrete a rich array of neurotrophic and angiogenic factors—including BDNF, NGF, GDNF, and VEGF—that stimulate synaptic plasticity and support local neurovascular perfusion. Complementing the cells, WJ-MSC exosomes act as nanoscale biological couriers that cross the blood-brain barrier and deliver neuroprotective proteins and microRNAs directly into stressed cortical neurons. This vesicular cargo helps stabilize mitochondrial energy production, reduce oxidative membrane damage, and support cholinergic and glutamatergic synaptic signaling. Together, they create a more supportive biochemical environment for brain network resilience.
Tailored Multi-Route Protocols Led by Uzm. Dr. Cihan Bolat
Every patient's cognitive stage, brain MRI, vascular health, and caregiver support system is reviewed individually before we recommend a treatment plan in Istanbul. Depending on clinical suitability, our physicians combine intrathecal CSF administration, systemic intravenous infusions, and non-invasive intranasal exosome delivery to engage both central and systemic pathways. All procedures are scheduled in a calm, family-centered clinical setting while keeping your prescribed memory medications fully intact.
Our treatment approach & administration routes
How our proposed Wharton's jelly MSC and exosome protocols work
- 01
Intrathecal WJ-MSC Administration
Intrathecal delivery places Wharton's jelly MSCs directly into the cerebrospinal fluid via a gentle lumbar procedure—performed with or without sedation depending on patient comfort and clinical assessment. By bypassing the blood-brain barrier, the cells circulate through the CSF to bathe the cerebral cortex and hippocampal structures in neurotrophic growth factors (BDNF, NGF, GDNF) and anti-inflammatory cytokines. This central paracrine signaling directly targets overactive microglia and supports synaptic resilience within memory circuits. Our physicians select this route when direct central nervous system trophic support is clinically appropriate.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 02
Intravenous WJ-MSC Administration
Intravenous infusion delivers Wharton's jelly MSCs systemically to regulate peripheral immune activation and systemic inflammatory cytokines that cross-talk with the aging brain. Through paracrine secretion and immune-cell modulation, intravenous MSCs help calm systemic inflammaging and support vascular endothelial repair across cerebral microvessels. Healthier microvascular perfusion improves oxygen and nutrient transport to cortical tissues while supporting blood-brain barrier stability. This route provides essential whole-body immunomodulatory foundation for neurological care.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 03
Intravenous WJ-MSC Exosome Administration
WJ-MSC exosomes are concentrated nanoscale extracellular vesicles carrying neuroprotective proteins, growth factors, and regulatory microRNAs that traverse the circulation and blood-brain barrier. Once absorbed by neurons, astrocytes, and endothelial cells, exosomal cargo helps downregulate neuro-inflammatory signaling, buffer oxidative stress, and support synaptic maintenance. Because exosomes are cell-free nanoparticles, they deliver rapid intercellular repair instructions without requiring cellular engraftment. Pairing intravenous exosomes with WJ-MSCs amplifies both immediate and sustained biological signaling.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 04
Intranasal Exosome Administration
Intranasal administration applies purified WJ-MSC exosomes to the upper nasal cavity to engage the olfactory and trigeminal nerve pathways leading toward the frontal cortex, limbic system, and hippocampus. Translational studies explore this non-invasive nose-to-brain route as a gentle way to deliver neurotrophic vesicles toward central memory networks without discomfort. While the exact fraction of intranasal exosomes reaching deep human cortical structures remains under clinical investigation, it serves as an ideal non-invasive complement to intravenous and intrathecal administration. Families appreciate its comfort and ease during the Istanbul treatment stay.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
What we aim to achieve
Therapeutic objectives and functional outcomes we track
Before treatment in Istanbul, our physicians establish your clinical baseline and define realistic biological and functional objectives to track during follow-up.
- 01
Cognitive Clarity & Memory Engagement
Tracking standardized cognitive assessments, word finding, and short-term recall alongside your neurologist. By calming hippocampal neuroinflammation and supplying BDNF and NGF, the protocol aims to support clearer mental processing and sustained cognitive engagement.
- 02
Daily Independence & Familiar Orientation
Monitoring how comfortably the patient navigates home routines, dressing, meals, and familiar environments. Supporting synaptic connectivity and cerebral microcirculation aims to help preserve practical day-to-day autonomy for longer.
- 03
Sleep Rhythm, Mood & Behavioral Calm
Evaluating nighttime sleep continuity, sundowning restlessness, apathy, and emotional steadiness. Regulating neuro-immune stress and autonomic balance often helps patients experience more restorative sleep and calmer daytime mood.
- 04
Social Connection & Communication Fluency
Observing conversation flow, recognition, and interaction with family members and caregivers. When inflammatory brain fatigue is reduced and trophic signaling is supported, patients often show more consistent daytime alertness and social presence.
How treatment is personalized
How our medical team evaluates your records and designs your protocol
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat evaluates your neurological profile to design a tailored multi-route regenerative program.
Medical history & reports we request
- Confirmed neurological diagnosis, cognitive stage, and symptom timeline
- Recent brain MRI or CT report and relevant laboratory panels
- Complete list of current memory, vascular, and systemic medications
- Assessment of daily function, mobility, and travel comfort with a family companion
- Medical review by Uzm. Dr. Cihan Bolat to tailor routes and dosing
Clinical suitability & protocol checks
- Patients continue their prescribed Alzheimer's medications without interruption before and during their stay in Istanbul.
- We plan every visit around a calm, supportive schedule with an accompanying family member or caregiver present throughout consultations and treatment.
- Written aftercare guidance and remote follow-up checkpoints help families track daily engagement, sleep, and cognitive function after returning home.
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
- 01
Contact us & share your medical reports
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
- 02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
- 03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
- 04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Transparent Istanbul pricing tailored to your protocol
After our medical team evaluates your records, we provide a written proposal explaining the recommended Wharton's jelly MSC and exosome preparations, administration routes, intended objectives, stay timeline, and itemized costs.
For 2026 planning context, targeted exosome and local orthopedic protocols typically range from $3,500–$6,500, while comprehensive Wharton's jelly MSC and exosome programs range from $7,000–$18,000. Your exact cost is confirmed after your medical evaluation.
- Patients continue their prescribed Alzheimer's medications without interruption before and during their stay in Istanbul.
- We plan every visit around a calm, supportive schedule with an accompanying family member or caregiver present throughout consultations and treatment.
- Written aftercare guidance and remote follow-up checkpoints help families track daily engagement, sleep, and cognitive function after returning home.
What your written treatment proposal explains
- 01
Which Wharton's jelly MSC, exosome, or combined protocol is proposed for your condition?
- 02
Which administration routes are recommended and how do they work biologically?
- 03
What are the intended therapeutic objectives and expected stay length in Istanbul?
- 04
What is the itemized cost and how does 1, 3, and 6-month follow-up work after treatment?
Evidence & important considerations
Published clinical research and important considerations
Below is a summary of published human studies, investigated mechanisms, and important limitations relevant to regenerative medicine for this condition.
01 Allogeneic mesenchymal stromal cell phase 1 study
Open study- Product
- Allogeneic mesenchymal stromal cell preparation
- Route
- Intravenous infusion
- Study design
- Randomized, placebo-controlled, dose-escalation clinical trial
- Finding
- The clinical trial demonstrated short-term safety, tolerability, and feasibility of allogeneic MSC infusion in patients with mild-to-moderate Alzheimer's disease, alongside exploratory biomarker assessments.
- Limitation
- Early-phase sample sizes require larger follow-up studies to define long-term cognitive trajectories and optimal multi-route dosing schedules.
Scientific references
Clinical studies and scientific references
FAQ
Frequently asked questions about this treatment
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.